Melanoma Institute Australia is proud to present an evening with our multidisciplinary experts to update GPs on the latest developments in the diagnosis and management of early melanoma.

As this is a hybrid event, you’re invited to join us either in person in Sydney at The Poche Centre or from the comfort of your home online. Our face-to-face guests will be invited to join us for light refreshments, drinks and an opportunity to network with your peers before the presentations commence.

PROGRAM:*

• Tips and tricks for detecting early melanoma – Prof Pascale Guitera (Dermatologist)
• Practical surgery for managing early melanoma – A/Prof Alexander van Akkooi (Surgical Oncologist)
• The role of radiotherapy in early melanoma – Prof Angela Hong (Radiation Oncologist)
• The increasing role of systemic therapy in early melanoma – Prof Georgina Long AO (Medical Oncologist)

The evening will conclude with an engaging case study panel discussion and Q&A led by our host A/Prof Sydney Ch’ng (Surgical Oncologist and Chair of MIA’s Education Committee) and featuring our multidisciplinary speakers and special guest, A/Prof Paul Fishburn (Skin Cancer GP).

Location: You have the option to join us:

• Face-to-face in Sydney at The Poche Centre (40 Rocklands Rd, Wollstonecraft)
• Online from the comfort of your home

Time: 6:30pm to 8:00pm (Note: Our face-to-face guests are invited to join us for light refreshments, drinks and an opportunity to network from 6pm)

Cost: Free

CPD: A Certificate of Attendance will be given to attendees after the event. Details of CPD accreditation coming soon.

RSVP: By 6 March 2023. Note that ticket numbers are strictly limited for our face-to-face event and we encourage you to register early if you’d like to attend in person.

Safety at our event: Please follow COVID-safe practices when attending our event and stay home if you are feeling unwell. If you can no longer attend due to COVID-19, please contact us.

This educational event is an initiative of Melanoma Institute Australia.

MIA’s Education Program is proudly supported through unrestricted educational grants from: MSD, Bristol Myers Squibb and HEINE.

*Program may be subject to change.